Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald S Go

Showing results (171-180 of 402) with videos related to

Pageof 41
Sort By:
Blood Advances|May 9, 2022
Complement gene variant effect on relapse of complement-mediated thrombotic microangiopathy after eculizumab cessationAldo A Acosta-Medina, Ann M Moyer, Ronald S Go, et al.
European Journal of Neurology|October 26, 2024
Central nervous system crystal-storing histiocytosis: A case report and literature reviewNabeela Nathoo, Daniel P Larson, Yong Guo, et al.
Blood Cancer Journal|January 25, 2020
The significance of genetic mutations and their prognostic impact on patients with incidental finding of isolated del(20q) in bone marrow without morphologic evidence of a myeloid neoplasmAishwarya Ravindran, Rong He, Rhett P Ketterling, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 28, 2019
Neoadjuvant vs. adjuvant chemotherapy for cholangiocarcinoma: A propensity score matched analysisSiddhartha Yadav, Hao Xie, Irbaz Bin-Riaz, et al.
American Journal of Hematology|April 22, 2020
The differential diagnosis of basophilia in patients undergoing BCR-ABL testingCaleb J Smith, Lindsey Ann Kluck, Gordon J Ruan, et al.
Mayo Clinic Proceedings|August 6, 2019
Outcome of Myelodysplastic Syndromes Over Time in the United States: A National Cancer Data Base Study From 2004-2013Aref Al-Kali, Darci Zblewski, James M Foran, et al.
International Journal of Laboratory Hematology|June 6, 2021
Interpreting sulfhemoglobin and methemoglobin in patients with cyanosis: An overview of patients with M-hemoglobin variantsAruna Rangan, Michelle E Savedra, Camila Dergam-Larson, et al.
International Journal of Dermatology|March 8, 2023
Cutaneous involvement in VEXAS syndrome: clinical and histopathologic findingsAlexander S Hines, Nessa A Mohandesi, Julia S Lehman, et al.
Blood Cancer Journal|February 23, 2022
Isolated anemia in patients with large granular lymphocytic leukemia (LGLL)Youssef Salama, Fang Zhao, Jennifer L Oliveira, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2012
Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisoneTina Marie Green, Ken H Young, Carlo Visco, et al.
Pageof 41

Showing results (171-180 of 402) with videos related to

Sort By:
Pageof 41
Blood Advances|May 9, 2022
Complement gene variant effect on relapse of complement-mediated thrombotic microangiopathy after eculizumab cessationAldo A Acosta-Medina, Ann M Moyer, Ronald S Go, et al.
European Journal of Neurology|October 26, 2024
Central nervous system crystal-storing histiocytosis: A case report and literature reviewNabeela Nathoo, Daniel P Larson, Yong Guo, et al.
Blood Cancer Journal|January 25, 2020
The significance of genetic mutations and their prognostic impact on patients with incidental finding of isolated del(20q) in bone marrow without morphologic evidence of a myeloid neoplasmAishwarya Ravindran, Rong He, Rhett P Ketterling, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 28, 2019
Neoadjuvant vs. adjuvant chemotherapy for cholangiocarcinoma: A propensity score matched analysisSiddhartha Yadav, Hao Xie, Irbaz Bin-Riaz, et al.
American Journal of Hematology|April 22, 2020
The differential diagnosis of basophilia in patients undergoing BCR-ABL testingCaleb J Smith, Lindsey Ann Kluck, Gordon J Ruan, et al.
Mayo Clinic Proceedings|August 6, 2019
Outcome of Myelodysplastic Syndromes Over Time in the United States: A National Cancer Data Base Study From 2004-2013Aref Al-Kali, Darci Zblewski, James M Foran, et al.
International Journal of Laboratory Hematology|June 6, 2021
Interpreting sulfhemoglobin and methemoglobin in patients with cyanosis: An overview of patients with M-hemoglobin variantsAruna Rangan, Michelle E Savedra, Camila Dergam-Larson, et al.
International Journal of Dermatology|March 8, 2023
Cutaneous involvement in VEXAS syndrome: clinical and histopathologic findingsAlexander S Hines, Nessa A Mohandesi, Julia S Lehman, et al.
Blood Cancer Journal|February 23, 2022
Isolated anemia in patients with large granular lymphocytic leukemia (LGLL)Youssef Salama, Fang Zhao, Jennifer L Oliveira, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2012
Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisoneTina Marie Green, Ken H Young, Carlo Visco, et al.
Pageof 41